CD71 binding fibronectin type III domains
US11628222B2 · kind B2 · utility
2Cited by
54References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2020 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Feb 12, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to polypeptides, such as fibronectin type III (FN3) domains that can bind CD71, their conjugates, isolated nucleotides encoding the molecules, vectors, host-cells, as well as methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.